In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished suceptibility to glycopeptides [1]

1. Cercenado, E.
2. Cercenado, S.
3. Gómez, J.A.
4. Bouza, E.